Glepaglutide (ZP1848) acetate is a long-acting glucagon-like peptide-2 (GLP-2) analogue and a potent GLP-2 receptor (GLP-2R) agonist. It significantly reduces fecal output and enhances intestinal absorption while also mitigating inflammation in the small intestine. Glepaglutide acetate is relevant in researching inflammatory bowel disease (IBD) and Crohns disease [1] [2] [3].
Molecular Weight:
4376.13
Formula:
C199H329N53O57
Target:
Glucagon Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
